Table 2.
Series | Type of Valve | h/o CVA | h/o PVD | Renal disease | STS score | EuroSCORE |
---|---|---|---|---|---|---|
Makkar et al. [42] | Sapien | 48 (27%) | 54 (30%) | 11.2 | 26.4 | |
Kodali et al. [14] | Sapien | 95 (27%) | 148 (43%) | 11.8 | 29.3 | |
Thomas et al. [12, 13] | Sapien | 49 (11%) | 121 (26%) | 25.7 | ||
Thomas et al. [12, 13] | Sapien | 161 (28%) | 189 (33%) | 29.1 | ||
Himbert et al. [10] (TF) | Sapien | 4 (8%) | 16 (31%) | 15 | 25 | |
Himbert et al. [10] (TA) | Sapien | 7 (30%) | 12 (52%) | 18 | 28 | |
Grube et al. [9] | CoreValve | 11 (8%) | 28 (21%) | 38 (28%) | 8.9 | 23.4 |
Litzler et al. [15] | Sapien | 6 (10%) | 27.5 | |||
Tamburino et al. [43] | CoreValve | 48 (7%) | 127 (19%) | 154 (23%) | 23 | |
Avanzas et al. [17] | CoreValve | 16 | ||||
Kempfert et al. [11] | Sapien | 142 (48%) | 8 (3%) | 12 | 31 | |
Gotzmann et al. [18] | CoreValve | 21 | ||||
Bleiziffer et al. [19] | Sapien and CoreValve | 26 (11%) | 61 (27%) | 48 (21%) | 7 | 21 |